Albumin
Albumins unique properties offer unlimited potential in the field of medical science.
Learn moreAlbumedix Ltd., a recognized global leader in recombinant human albumin specializing in the enablement of advanced therapies, announces the completed expansion of the company’s commercial-scale manufacturing facility, alongside with the establishment of a new Technology Centre equipped with state-of-the-art laboratories at its UK-based campus in Nottingham.
Read moreAlbumedix Ltd., an enabler of advanced therapies and world leader in recombinant human albumin, announced today that they have entered into a distribution agreement with established and well recognized reagent supplier FUJIFILM Wako Pure Chemical Corporation in Japan and China including Hong Kong.
Read moreIt has now been three weeks since Albumedix´ US Business Development Director Brian Macdonald attended VSOHIO21
Read moreIn a conversation with Alessandro Mantell from Mantell Associates, Jonas and Gregor are happy to join the list of previous podcast guests and share their experience of COVID-19 and how it has been adapting to life and business during the Global Pandemic.
Read moreAlbumedix Ltd. (‘Albumedix’), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with the Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
Read moreAlready a month into the year 2021 and we are picking up where we left off, while looking forward to a year where we can get a bit more back to normal.
Read moreThe current global pandemic has shined a light on the importance of diagnostic testing, especially for COVID-19. As the coronavirus continues to sweep across the globe, it has never been more vital to focus efforts on identifying those infected with the disease to delay and halt the spread of infection. A coordinated effort is needed to accelerate research and, whilst vaccine roll-out is still only in the early stages, the world is more cognizant of how reliable diagnostic testing is a valuable tool to save lives.
Read moreAlbumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rHA), announced today the submission of Drug Master Files (DMFs) to the Pharmaceutical and Medical Device Agency (PMDA) in Japan.
Read moreApproximately one month ago our American Business Development Directors, Gary Willingham and Brian MacDonald, participated in the virtual American Drug Delivery and Formulation Summit. Albumedix has been a long-standing supporter of both the American and European DDF Summits and as such, we always look forward to catching up with collaborators and industry partners - although this time virtually.
Read moreDid you know that unlike other recombinant human albumin manufacturers, Albumedix are so much more than simply ‘an albumin supplier’? When you work with us, you also get access to 100 brilliant minds behind the vial, including a dedicated Business Development Director responsible for managing your account.
Read moreLast week, our CEO (Jonas Skjødt Møller) participated in a virtual strategy panel discussion at the Bio Integrates 2020 conference to discuss the still urgently pressing issue on how to overcome the apparent scalability and health economic challenges associated with advanced therapies. Speaking in the panel was other experts from within the field, including:
Read moreMeet Dangerous Dave Phillipson; a formidable, Nottingham based, three-time Paralympian in tennis who took to the water in 2017 and is now paracanoeing his way to Tokyo 2021.
Read moreMeet Helen Rawsthorne. Helen is a Senior Research Scientist within Albumedix and a truly brilliant example of our many brilliant minds. Presently in her 7th year working for the company, the following interview will take you through Helen's background, her role within Albumedix and give you a sneak preview into what our Technical Group get up to in the day.
Read moreAlbumedix are thrilled to be able to continue supporting the Nottinghamshire Wildlife Trust in their endeavours to protect and restore the beautiful environment and wildlife both on our doorstep and across the region.
Read moreAlbumedix is a world leading manufacturer of recombinant human albumin (rHA), and as such our manufacturing plant is the core of our business. As a company, we talk a lot about our rHA products, how they’re useful in different applications and what benefits they can bring to final therapies for patients worldwide. However, we don’t talk as much about the amazing people within our business that make the magic happen.
Read moreIn December, Albumedix held a 'Capping off Ceremony' to celebrate the brand new, four-storey manufacturing plant extension being confirmed as watertight!
Read more